JACOB MANDEL to Male
This is a "connection" page, showing publications JACOB MANDEL has written about Male.
Connection Strength
0.232
-
Hypertrophic Olivary Degeneration Postoperatively Following Pilocytic Astrocytoma Resection. World Neurosurg. 2022 09; 165:18-19.
Score: 0.029
-
Effect of health disparities on overall survival of patients with glioblastoma. J Neurooncol. 2019 Apr; 142(2):365-374.
Score: 0.023
-
Newly diagnosed ganglioglioma in an adult patient with multiple sclerosis. J Neurol Sci. 2016 Oct 15; 369:51-52.
Score: 0.020
-
Delayed imaging abnormalities of neuro-invasive West Nile virus in cancer patients. J Neurol Sci. 2015 Mar 15; 350(1-2):115-7.
Score: 0.018
-
Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution. J Neurooncol. 2014 Dec; 120(3):597-605.
Score: 0.017
-
Lambrolizumab induced central nervous system (CNS) toxicity. J Neurol Sci. 2014 Sep 15; 344(1-2):229-31.
Score: 0.017
-
Seizure-presenting IDH-wildtype glioblastoma and the upregulation of a synaptic signature. J Neurosurg. 2026 Jul 01; 145(1):157-167.
Score: 0.010
-
PD-L1 positivity predicts a unique hyperaggressive tumor group within MenG C meningiomas. JNCI Cancer Spectr. 2026 Mar 03; 10(2).
Score: 0.010
-
Characterization of the tumor microbiome of brain metastases and glioblastoma reveals tumor-type-specific and location-specific microbial signatures. Nat Cancer. 2025 Nov; 6(11):1761-1776.
Score: 0.009
-
Discontiguous recurrences of IDH-wildtype glioblastoma share a common origin with the initial tumor and are frequently hypermutated. Acta Neuropathol Commun. 2025 01 16; 13(1):9.
Score: 0.009
-
Height in adolescence as a risk factor for glioma subtypes: a nationwide retrospective cohort study of 2.2 million subjects. Neuro Oncol. 2021 08 02; 23(8):1383-1392.
Score: 0.007
-
Intracranial Solitary Fibrous Tumor of the Skull Base: 2 Cases and Systematic Review of the Literature. World Neurosurg. 2021 05; 149:e345-e359.
Score: 0.007
-
Height as a risk factor in meningioma: a study of 2 million Israeli adolescents. BMC Cancer. 2020 Aug 20; 20(1):786.
Score: 0.006
-
Treatment strategies for glioblastoma in older patients: age is just a number. J Neurooncol. 2019 Nov; 145(2):357-364.
Score: 0.006
-
Neurologic complications of immune checkpoint inhibitors. J Neurooncol. 2018 May; 137(3):601-609.
Score: 0.005
-
Spinal Dural Arteriovenous Fistula and Concomitant Intramedullary Spinal Lesion. Can J Neurol Sci. 2018 03; 45(2):238-239.
Score: 0.005
-
Intracranial Erdheim-Chester Disease Mimicking Parafalcine Meningioma: Report of Two Cases and Review of the Literature. World Neurosurg. 2018 Feb; 110:365-370.
Score: 0.005
-
Radiographic patterns of progression with associated outcomes after bevacizumab therapy in glioblastoma patients. J Neurooncol. 2017 Oct; 135(1):75-81.
Score: 0.005
-
Intraventricular Cavernomas of the Third Ventricle: Report of 2 Cases and a Systematic Review of the Literature. World Neurosurg. 2017 Sep; 105:935-943.e3.
Score: 0.005
-
Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. J Neurooncol. 2015 Nov; 125(2):401-10.
Score: 0.005
-
Wound healing complications in brain tumor patients on Bevacizumab. J Neurooncol. 2015 Sep; 124(3):501-6.
Score: 0.005
-
Venous thromboembolism (VTE) and glioblastoma. J Neurooncol. 2015 Aug; 124(1):87-94.
Score: 0.005
-
Survival outcome of early versus delayed bevacizumab treatment in patients with recurrent glioblastoma. J Neurooncol. 2014 Aug; 119(1):135-40.
Score: 0.004